(S)-3,5-DICHLORO-N-[(1-ETHYL-2-PYRROLIDINYL)METHYL]-2,6-DIHYDROXY-BENZAMIDE HYDROBROMIDE
![(S)-3,5-DICHLORO-N-[(1-ETHYL-2-PYRROLIDINYL)METHYL]-2,6-DIHYDROXY-BENZAMIDE HYDROBROMIDE Structure](https://image.chemsrc.com/caspic/107/113310-88-6.png)
(S)-3,5-DICHLORO-N-[(1-ETHYL-2-PYRROLIDINYL)METHYL]-2,6-DIHYDROXY-BENZAMIDE HYDROBROMIDE structure
|
Common Name | (S)-3,5-DICHLORO-N-[(1-ETHYL-2-PYRROLIDINYL)METHYL]-2,6-DIHYDROXY-BENZAMIDE HYDROBROMIDE | ||
|---|---|---|---|---|
| CAS Number | 113310-88-6 | Molecular Weight | 414.12200 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C14H19BrCl2N2O3 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | N/A | |
|
An improved HPLC system for the analysis and purification of organic amine radiopharmaceuticals.
Appl. Radiat. Isot. 40 , 91-92, (1989) This paper describes the separation of lipophilic amine radiopharmaceuticals on normal phase silica using a reversed phase type eluant. This class of compound usually gives very poor peak symmetry on reversed phase columns. However, excellent separation of a ... |
|
|
Labelled agents for PET studies of the dopaminergic system--some quality assurance methods, experience and issues.
Appl. Radiat. Isot. 41 , 483-492, (1990) Practical methods are described for the quality assurance of three labelled agents (L-6-[18F]fluoro-DOPA, S-[N-methyl-11C]nomifensine and [O-methyl-11C]raclopride) now produced regularly for PET studies of the dopaminergic system in man. These include indirec... |
Journals:
More...